Can-Fite BioPharma Ltd. (TLV:CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.900
0.00 (0.00%)
Apr 1, 2025, 4:45 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 59.01 million as of April 1, 2025. Its market cap has increased by 45.99% in one year.
Market Cap
59.01M
Enterprise Value
41.43M
Revenue
2.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.90
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 59.01M, an increase of 267.95%. That is a compound annual growth rate of 7.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 63.85B |
| Danel (Adir Yeoshua) | 2.16B |
| Kamada | 1.46B |
| Bait Bakfar | 897.25M |
| Novolog (Pharm-Up 1966) | 845.44M |
| Ilex Medical | 741.81M |
| BrainsWay | 667.22M |
| SofWave Medical | 555.35M |